Example: Heart Attack

Search clinical trials for: Methamphetamine

Total 22 results

  • NCT05379959
    Recruiting
    Effects of Stimulants on Behavioral and Neural Markers of Social Motivation, Ability, and Neural Markers of Social Function
    Conditions: Stimulant Use, MDMA ('Ecstasy'), Social Behavior, Motivation
  • NCT04642820
    Recruiting
    Drugs Brain and Behavior (DDP)
    Conditions: Stimulant Use
  • NCT03973489
    Recruiting
    Effects of Genotype on Resting State Connectivity During Methamphetamine Administration
    Conditions: Methamphetamine-dependence
  • NCT03825536
    Recruiting
    Effect of Methamphetamine on Residual Latent HIV Disease Study
    Conditions: HIV-1-infection, Methamphetamine-dependence
  • NCT05266716
    Completed
    Field Study of a Digital Therapeutic Platform to Facilitate Treatment for Methamphetamine-Primary Stimulant Use Disorder
    Conditions: Methamphetamine Abuse
  • NCT05206175
    Recruiting
    Demonstration of a Digital Care Program for Methamphetamine Use Disorder
    Conditions: Methamphetamine Abuse
  • NCT05003076
    Recruiting
    Brain Function and EEG
    Conditions: Healthy, Mood
  • NCT04178993
    Completed
    Behavioral Effects of Drugs (Inpatient): 40 [Methamphetamine, Methylphenidate, Duloxetine]
    Conditions: Methamphetamine Use Disorder
  • NCT04563962
    Completed
    Contingency Management for PrEP Adherence and/or Methamphetamine Use
    Conditions: Methamphetamine-dependence, HIV-1-infection
  • NCT03470480
    Recruiting
    rTMS for Craving in Methamphetamine Use Disorder
    Conditions: Methamphetamine Abuse, Substance Use Disorders, Stimulant Dependence, Methamphetamine-dependence, Stimulant Use, Transcranial Magnetic Stimulation
  • NCT04614584
    Recruiting
    Mirtazapine and Methamphetamine Drug-drug Interaction Study
    Conditions: Methamphetamine Use Disorder, Drug Interaction, Cardiovascular Abnormalities
  • NCT03226223
    Completed
    Pharmacogenetics of Naltrexone for Stimulant Abuse
    Conditions: Substance Use Disorders, Methamphetamine Abuse
  • NCT03106571
    Terminated
    Study of Pomaglumetad and Methamphetamine
    Conditions: Methamphetamine Use Disorder
  • NCT02058966
    Completed
    Pilot Study of Entacapone for Methamphetamine Abuse
    Conditions: Methamphetamine Dependence
  • NCT03790618
    Unknown status
    Effect of Stimulant Drugs on Social Perception
    Conditions: Effects of MDMA on Healthy Human Volunteers
  • NCT01967381
    Completed
    Targeting GABA and Opioid Systems for a Pharmacotherapy for Methamphetamine Abuse
    Conditions: Methamphetamine Abuse, Methamphetamine Dependence
  • NCT02323048
    Completed
    Acquisition of Responses to a Methamphetamine-associated Cue in Healthy Humans
    Conditions: Substance Abuse
  • NCT01843205
    Completed
    Buspirone as a Candidate Medication for Methamphetamine Abuse
    Conditions: Methamphetamine Dependence, Methamphetamine Abuse
  • NCT00252434
    Terminated
    Behavioral Therapy Development for Methamphetamine Abuse
    Conditions: Depression, Drug Abuse, Sexually Transmitted Diseases
  • NCT00680511
    Completed
    Development of a Family-Based Treatment for Adolescent Methamphetamine Use
    Conditions: Behavior and Mental Disorders, Methamphetamine Disorders
  • NCT00829634
    Completed
    Steady State Kinetics of l-Methamphetamine and Validation of Sensitivity of Dose Estimation
    Conditions: Nasal Congestion
  • NCT01529892
    Withdrawn
    The Impact of Genetic Variation in CYP2D6 on the Pharmacokinetics and Pharmacodynamics of Methamphetamine
    Conditions: Methamphetamine Metabolism, CYP2D6 Genotype

Medical Conditions

Sponsors and Collaborators

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations